首页 › 胶质母细胞瘤 › 密苏里州 › St. Louis
St. Louis MO 胶质母细胞瘤临床试验
12项针对 胶质母细胞瘤的研究正在 St. Louis及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本(英文)
正在为研究招募参与者?将此页面置顶展示 — $99 / 30天 →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
招募中2 期
- Washington University School of Medicine Siteman Cancer Center, St Louis
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
招募中1 期
- Washington University School of Medicine, St Louis
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
招募中1/2 期
- Washington University School of Medicine in St. Louis, St Louis
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
招募中3 期
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- 以及另外 5 项
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
招募中1 期
- Siteman Cancer Center at Washington University, St Louis
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
招募中3 期
- Washington University, St Louis
Neurosurgical Neuronavigation Using Resting State MRI and Machine Learning
招募中观察性研究
- Washington University School of Medicine, St Louis
Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
招募中1/2 期
- Washington University School of Medicine, St Louis
Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
招募中早期 I 期
- Washington University School of Medicine, St Louis
Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
招募中
- Washington University School of Medicine, St Louis
Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
招募中2 期
- Washington University School of Medicine, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, St Louis
其他城市的 胶质母细胞瘤试验
- New York City, NY30 项研究
- Boston, MA28 项研究
- Houston, TX26 项研究
- Los Angeles, CA24 项研究
- Durham, NC20 项研究
- San Francisco, CA17 项研究
- Chicago, IL15 项研究
- Washington, DC15 项研究
- Columbus, OH14 项研究
- Miami, FL14 项研究
- Rochester, MN13 项研究
- Jacksonville, FL13 项研究
St. Louis的其他研究
- 非小细胞肺癌73 项研究
- 乳腺癌64 项研究
- 转移性癌症54 项研究
- 结直肠癌50 项研究
- 癌症(所有类型)46 项研究
- 前列腺癌46 项研究
- 肺癌39 项研究
- 卵巢癌38 项研究
- 胰腺癌33 项研究
- 子宫内膜癌29 项研究
- 头颈鳞状细胞癌28 项研究
- 心力衰竭26 项研究
数据来自 ClinicalTrials.gov,检索日期:2026年10月6日。每项研究自行设定入选标准,由研究团队决定谁能参与。